维普中文期刊产品整合服务
18篇 您的检索式:作者名="Shami HA"
    题名 作者 年代 出处 被引量
1Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetesmellitus显示文摘Patil HR At Badarin FJ A1 Shami HA 2012Am J Cardiol2012,110,:1
2The irnmunomodulato- ry agents lenalidomide and thalidomide for treatment of the my- elodysplastic syndromes: aclinical practice guideline 显示文摘Leitch HA Buckstein R Shamy A 2013Crit Rev Oncol Hematol2013,85,2:1
3Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR Al Badarin FJ A1 Shami HA 2012The American journal of cardiology2012,110,6:1
4Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mel itus显示文摘Patil HR Al Badarin FJ Al Shami HA 0,,06:1
5Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR Al Badarin F J Al Shami HA 2012Am J Cardiol2012,110,6:1
6Meta analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR A1 Badarin FJ A1 Shami HA 2012Am J Cardiol2012,110,6:1
7An easy and inexpensive method for quantitative analysis of endothelial damage by using vital dye staining and adobe photoshop software显示文摘Saad HA Terry MA Shamie N 2008Cornea2008,27,7:1
8An easy and inexpensive method for quantitative analysis of endothelial damage by using vital dye staining and Adobe Photoshop software显示文摘Saad HA Terry MA Shamie N 2008Comea2008,27,7:1
9Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR Badarn FJ Shami HA 2012Am J Cardiol2012,110,6:1
10Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR Al Badarin FJ Al Shami HA 0,,06:1
11Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR A1 Badarin FJ AI Shami HA 2012Am J Cardiol2012,110,:1
12Meta- analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus 显示文摘Patil HR A1 Badarin FJ A1 Shami HA 2012Am J Cardio12012,110,6:1
13The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syn- dromes: a clinical practice guideline 显示文摘Leitch HA Buckstein R Shamy A 2013Crit Rev Oncol Hematol2013,85,2:1
14Meta-analysis of effect of DPP-4 inhibitors on the Cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR AI Badarin F J AI Shami HA 2012Am J Cardiol2012,110,:1
15Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mel itus显示文摘Patil HR Al Badarin FJ Al Shami HA 0,,06:1
16Meta-analysis of effect of dipeptidyl peptidase- inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR AI Badarin FJ A1 Shami HA 2012Am J Cardiol2012,110,:1
17Meta-analysis of effect of DPP-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus 显示文摘Patil HR Al Badarin FJ Al Shami HA 2012Am J Cardiol2012,110,6:1
18Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘Patil HR Al Badarin FJ Al Shami HA 0,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费